Effects of inhibiting connexin43 on expression of fibroblast growth factor in prolactinomas in rats

References

• Dietrich HH, Dacey RG Jr. Molecular keys to the problems of cerebral vasospasm. Neurosurgery. 2000;46:517–30.10.1097/00006123-200003000-00001
   PubMed Web of Science ®Google Scholar
• Cronier L, Crespin S, Strale PO, Defamie N, Mesnil M. Gap junctions and cancer: new functions for an old story. Antioxid Redox Signal. 2009;11:323–38.10.1089/ars.2008.2153
   PubMed Web of Science ®Google Scholar
• Lewis BM, Pexa A, Francis K, Verma V, McNicol AM, Scanlon M, et al. Adenosine stimulates connexin 43 expression and gap junctional communication in pituitary folliculostellate cells. FASEB J. 2006;20(14):2585–7.10.1096/fj.06-6121fje
   PubMed Web of Science ®Google Scholar
• Vitale ML, Carding J, Gilula NB, Carbajal ME, Pelletier RM. Dynamics of connexin 43 levels and distribution in the mink (Mustela vison) anterior pituitary are associated with seasonal changes in anterior pituitary prolactin content. Biol Reprod. 2001;64:625–33.10.1095/biolreprod64.2.625
   PubMed Web of Science ®Google Scholar
• Soji T, Mabuchi Y, Kurono C, Herbert DC. Folliculo-stellate cells and intercellular communication within the rat anterior pituitary gland. Microsc Res Tech. 1997;39(2):138–49.10.1002/(ISSN)1097-0029
   PubMed Web of Science ®Google Scholar
• Gospodarowicz D, Ferrara N, Schweigerer L, Neufeld G. Structural characterization and biological functions of fibroblast growth factor. Endocr Rev. 1987;8(2):95–114.10.1210/edrv-8-2-95
   PubMed Web of Science ®Google Scholar
• Schechter J, Weiner R. Changes in Basic Fibroblast Growth Factor Coincident with Estradiol-Induced Hyperplasia of the Anterior Pituitaries of Fischer 344 and Sprague-Dawley Rats. Endocrinology. 1991;129(5):2400–8.10.1210/endo-129-5-2400
   PubMed Web of Science ®Google Scholar
• Heaney AP, Fernando M, Melmed S. Functional role of estrogen in pituitary tumor pathogenesis. J Clin Invest. 2002;109(2):277–83.10.1172/JCI0214264
   PubMed Web of Science ®Google Scholar
• Heaney AP, Horwitz GA, Wang Z, Singson R, Melmed S. Early involvement of estrogen-induced pituitary tumor transforming gene and fibroblast growth factor expression in prolactinoma pathogenesis. Nat Med. 1999;5(11):1317–21.10.1038/15275
   PubMed Web of Science ®Google Scholar
• Zimering MB, Katsumata N, Sato Y, Brandi ML, Aurbach GD, Marx SJ, Friesen HG. Increased basic fibroblast growth factor in plasma from multiple endocrine neoplasia type 1: relation to pituitary tumor. J Clin Endocrinol Metab. 1993;76(5):1182–7.
   PubMed Web of Science ®Google Scholar
• Shimon I, Melmed S. Management of pituitary tumors. Annals Int Med. 1998;129:472–83.10.7326/0003-4819-129-6-199809150-00009
   PubMed Web of Science ®Google Scholar
• MacLeod RM, Scapagnini U, Thorner MO. Pituitary microadenomas. New York, NY: Academic Press; 1980.p. 683–855.
   Google Scholar
• Van Thiel DH. Feminization of chronic alcoholic men: a formulation. Yale J Biol Med. 1979;52:219–25.
   PubMed Web of Science ®Google Scholar
• Banerjee SK, De A, Sarkar DK. Colocalization of prolactin and proliferating cell nuclear antigen in the anterior pituitary during estrogen-induced pituitary tumors. Cancer Lett. 1994;87:139–44.10.1016/0304-3835(94)90214-3
   PubMed Web of Science ®Google Scholar
• Evans WH, Martin PE. Gap junctions: structure and function. Mol Membr Biol. 2002;19:121–36.10.1080/09687680210139839
   PubMed Web of Science ®Google Scholar
• Morand I, Fonlupt P, Guerrier A, Trouillas J, Calle A, Remy C, et al. Cell-tocell communication in the anterior pituitary: evidence for gap junction-mediated exchanges between endocrine cells and folliculostellate cells. Endocrinology. 1996;137:3356–67.
   PubMed Web of Science ®Google Scholar
• Hentges S, Pastorcic M, De A, Boyadjieva N, Sarkar DK. Opposing actions of two transforming growth factor-beta isoforms on pituitary lactotropic cell proliferation. Endocrinology. 2000;141:1528–35.
   PubMed Web of Science ®Google Scholar
• Wang H, Zhang Y., Zhou A, Zhang R, Meng Q. Effects of silencing connexin43 on expression of pituitary tumor-transforming gene in prolactinomas. Neurol Res. 2015;37(February): 153–8.10.1179/1743132814Y.0000000419
   PubMed Web of Science ®Google Scholar
• Moscatelli D. High and low affinity binding sites for basic fibroblast growth factor on cultured cells: absence of a role for low affinity binding in the stimulation of plasminogen activator production by bovine capillary endothelial cells. J Cell Physiol. 1987;131(1):123–30.10.1002/(ISSN)1097-4652
   PubMed Web of Science ®Google Scholar
• Ferrara N, Schweigerer L, Neufeld G, Mitchell R, Gospodarowicz D. Pituitary follicular cells produce basic fibroblast growth factor. Proc Nat Acad Sci U.S.A. 1987;84(16):5773–7.10.1073/pnas.84.16.5773
   PubMed Web of Science ®Google Scholar
• Mallea-Gil MS, Cristina C, Perez-Millan MI, Villafañe AM, Ballarino C, Stalldecker G, Becu-Villalobos D. Invasive giant prolactinoma with loss of therapeutic response to cabergoline: expression of angiogenic markers. Endocr Pathol. 2009;20(1):35–40.10.1007/s12022-009-9057-3
   PubMed Web of Science ®Google Scholar
• McCabe CJ, Khaira JS, Boelaert K, Heaney AP, Tannahill LA, Hussain S, Mitchell R, Olliff J, Sheppard MC, Franklyn JA, Gittoes NJ. Expression of pituitary tumour transforming gene (PTTG) and fibroblast growth factor-2 (FGF-2) in human pituitary adenomas: relationships to clinical tumour behaviour. Clin Endocrinol. 2003;58(2):141–50.10.1046/j.1365-2265.2003.01598.x
   PubMed Web of Science ®Google Scholar
• Zou H, McGarry TJ, Bernal T, Kirschner MW. Identification of a vertebrate sister-chromatid separation inhibitor involved in transformation and tumorigenesis. Science. 1999;285(5426):418–22.10.1126/science.285.5426.418
   PubMed Web of Science ®Google Scholar
• Yu R, Melmed S. Pituitary tumor transforming gene an update. Front Horm Res. 2004;32:175–85.10.1159/000079044
   PubMed Web of Science ®Google Scholar
• Cristina C, Díaz-Torga GS, Goya RG, Kakar SS, Perez-Millán MI, Passos VQ, Giannella-Neto D, Bronstein MD, Becu-Villalobos D. PTTG expression in different experimental and human prolactinomas in relation to dopaminergic control of lactotropes. Mol Cancer. 2007;6: article 4.
   PubMed Web of Science ®Google Scholar